Meet Bioneer at one of the most interesting events within preclinical research.

At the 17th annual World Preclinical Congress in Boston mid-June technologies, trends and innovations within drug discovery and translational research. The congress gathers experts with a variety of scientific backgrounds such as chemistry, biology, pharmacology, toxicology and engineering as well as researchers within a variety of disease areas such as cancer and neuronal diseases. Representatives from industry, academia and technology providers will be present to share their challenges, solutions and knowhow.

Together we will accelerate preclinical research across all therapeutic areas.

Bioneer has state-of-the-art technology platforms within important areas like drug formulation & characterization, human disease models, recombinant protein production, and molecular histology & detection.

At the congress we look forward to talking to fellow scientists in the program themes like ‘iPS Cells for Disease Modeling and Drug Discovery’, ‘Blood-Brain-barrier models’, ‘Preclinical Strategies in Oncology’ etc.

If you wish to meet with Bioneer in Boston, please contact CSO Christian Clausen via email or Sales & Business Development Manager Lovisa M. Sunesson via email.

For more information about the event, read here.

Share this post